Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-05

FDA Approved: LEVETIRACETAM — Supplemental Application (Prinston Pharmaceutical Inc.)

View source ↗

Summary

FDA approves a supplemental application for levetiracetam from Prinston Pharmaceutical Inc., indicating an update or expansion to the existing approval for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)